Neonplus Homeopathy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit 81.47%
(FY 2020)
- Ebitda 99.48%
(FY 2020)
- Net Worth -76.20%
(FY 2020)
- Total Assets -0.70%
(FY 2020)
About Neonplus Homeopathy
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madabattula Harinya, Veera Madabattula, Sirisha Tondapu, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999AP2017PTC105386
- Company No.
105386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Neonplus Homeopathy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veera Madabattula  | Managing Director | 10-Mar-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madabattula Harinya | Director | 10-Mar-2017 | Current |
| Sirisha Tondapu | Additional Director | 22-Oct-2018 | Current |
| Leelakumari Tondapu | Additional Director | 22-Oct-2018 | Current |
Financial Performance of Neonplus Homeopathy.
Neonplus Homeopathy Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 81.47% increase in profit. The company's net worth observed a substantial decline by a decrease of 76.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neonplus Homeopathy?
Unlock access to Neonplus Homeopathy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aurah Natureals India Private LimitedActive 12 years 6 monthsMadabattula Harinya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neonplus Homeopathy?
Unlock and access historical data on people associated with Neonplus Homeopathy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neonplus Homeopathy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neonplus Homeopathy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
